Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
NCT05222425
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Sars-cov-2
Interventions
DRUG:
Xagrotin
DRUG:
Green tea
Sponsor
Biomad AS